Ladenburg Announces the Virtual Oncology Innovators & Investors Symposium

November 05, 2024

Ladenburg Thalmann & Co. Announces the Virtual Oncology Innovators & Investors Symposium

New York, NY-November 5, 2024- Ladenburg Thalmann & Co. a leading investment bank focused on connecting innovative companies with capital markets, is pleased to announce the Oncology Innovators & Investors Symposium to be held virtually on December 12, 2024.

This event will bring together industry leading companies and investors to spotlight advancements in oncology and foster meaningful connections between innovators and key stakeholders in the investment community.

Event Highlights:

Presentations showcasing breakthrough oncological treatments and technologies
Q&A with Ladenburg analysts Aydin Huseynov and Matt Kaplan
One-on-one virtual meetings

"Our goal with the Oncology Innovators & Investors Symposium is to provide a platform where groundbreaking oncology companies can engage with investors actively seeking new opportunities," said Jeff Cohen, Director of Research, Ladenburg Thalmann. "This event will highlight the intersection of science and capital, advancing efforts to develop effective cancer treatments."

Event Details:

Date: December 12, 2024

Location: Virtual To register, please visit Registration or connect with your Ladenburg Institutional Representative.

Please note, all registration is subject to approval

Ladenburg Thalmann Biotechnology Analysts

Dr. Aydin Huseynov is Managing Director of Equity Research at Ladenburg Thalmann & Co. He specializes in biotechnology with a focus on oncology. He has 10 years of experience and has been a publishing analyst for 5 years. He earned his MBA from Duke, and his M.D. from Azerbaijan Medical University. He is a CFA charter holder

Matthew Kaplan is a Managing Director at Ladenburg Thalmann & Co. He specializes in the Biotechnology sector. He has 30+ years of experience and has been a publishing analyst for 24+ years. He earned his BS from the University of Michigan.

About Ladenburg Thalmann & Co.

Navigating Complexity, Empowering Growth: Tailored Financial Solutions for Middle-Market Innovators

Ladenburg Thalmann& Co., a subsidiary of Osaic, is an investment bank dedicated to supporting innovative companies through capital-raising activities, advisory services, and strategic events. Our mission is to deliver exceptional outcomes for our clients by aligning premium financial solutions with expert advice and unmatched service. Client success is our top priority, driving every decision we make. With a foundation rooted in tradition and a focus on innovation, we are committed to building lasting relationships and helping our clients thrive in an ever-evolving market landscape.